Fig. 1From: Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenomeCONSORT flow diagram of included samples that were analyzed with the MethylationEPIC BeadChip (n = 279). Samples were from testicular cancer survivors divided into four groups according to CBCT and MetS status. a CBCT cisplatin-based chemotherapy. b MetS metabolic syndromeBack to article page